相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Patients with major depressive disorder have lower cerebral serotonin 4 receptor binding than healthy controls
K. Koehler-Forsberg et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Convergent Mechanisms Underlying Rapid Antidepressant Action
Panos Zanos et al.
CNS DRUGS (2018)
Global arginine bioavailability ratio is decreased in patients with major depressive disorder
Toni Ali-Sisto et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Kynurenine pathway metabolism and the neurobiology of treatment resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy
A. P. Allen et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Side-effects associated with ketamine use in depression: a systematic review
Brooke Short et al.
LANCET PSYCHIATRY (2018)
Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders
G. Sanacora et al.
NEUROPSYCHOPHARMACOLOGY (2017)
The association between the hypothalamic pituitary adrenal axis and tryptophan metabolism in persons with recurrent major depressive disorder and healthy controls
F. J. H. Sorgdrager et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Antidepressant Actions of Ketamine Mediated by the Mechanistic Target of Rapamycin, Nitric Oxide, and Rheb
Maged M. Harraz et al.
NEUROTHERAPEUTICS (2017)
Decreased serum L-arginine and L-citrulline levels in major depression
S. Hess et al.
PSYCHOPHARMACOLOGY (2017)
Kynurenines: Tryptophan's metabolites in exercise, inflammation, and mental health
Igor Cervenka et al.
SCIENCE (2017)
Plasma sphingolipids and depressive symptoms in coronary artery disease
Adam Dinoff et al.
BRAIN AND BEHAVIOR (2017)
Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation
Francesco Saverio Bersani et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
Plasma Biomarkers of Poor Muscle Quality in Older Men and Women from the Baltimore Longitudinal Study of Aging
Ruin Moaddel et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Metabolomic signatures of drug response phenotypes for ketamine and esketamine in subjects with refractory major depressive disorder: new mechanistic insights for rapid acting antidepressants
D. M. Rotroff et al.
TRANSLATIONAL PSYCHIATRY (2016)
Inflammation: Depression Fans the Flames and Feasts on the Heat
Janice K. Kiecolt-Glaser et al.
AMERICAN JOURNAL OF PSYCHIATRY (2015)
Indoleamine 2,3-dioxygenase-dependent neurotoxic kynurenine metabolism mediates inflammation-induced deficit in recognition memory
Jillian M. Heisler et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: Evidences from animal and human studies
Gislaine Z. Reus et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2015)
Nitric Oxide-Related Biological Pathways in Patients with Major Depression
Andreas Baranyi et al.
PLOS ONE (2015)
Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review
Nicolas D. Iadarola et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2015)
Antidepressant-like effect of the mGluR5 antagonist MTEP in an astroglial degeneration model of depression
Helena Domin et al.
BEHAVIOURAL BRAIN RESEARCH (2014)
Reconceptualizing Adult Neurogenesis: Role for Sphingosine-1-Phosphate and Fibroblast Growth Factor-1 in Co-Ordinating Astrocyte-Neuronal Precursor Interactions
George Anderson et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2014)
Serotonin - Kynurenine Hypothesis of Depression: Historical Overview and Recent Developments
Gregory Oxenkrug
CURRENT DRUG TARGETS (2013)
Conceptual Confluence: The Kynurenine Pathway as a Common Target for Ketamine and the Convergence of the Inflammation and Glutamate Hypotheses of Depression
Andrew H. Miller
NEUROPSYCHOPHARMACOLOGY (2013)
Characterization of Acid Sphingomyelinase Activity in Human Cerebrospinal Fluid
Christiane Muehle et al.
PLOS ONE (2013)
Relationship of Ketamine's Plasma Metabolites with Response, Diagnosis, and Side Effects in Major Depression
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
The control of the balance between ceramide and sphingosine-1-phosphate by sphingosine kinase: Oxidative stress and the seesaw of cell survival and death
James R. Van Brocklyn et al.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY (2012)
Nitric oxide synthases: regulation and function
Ulrich Foerstermann et al.
EUROPEAN HEART JOURNAL (2012)
The Role of Indoleamine 2,3-Dioxygenase in a Mouse Model of Neuroinflammation-Induced Depression
Nikoletta Dobos et al.
JOURNAL OF ALZHEIMERS DISEASE (2012)
Mortality and Suicide Risk in Treatment-Resistant Depression: An Observational Study of the Long-Term Impact of Intervention
Bryan Olin et al.
PLOS ONE (2012)
Arginine bioavailability ratios are associated with cardiovascular mortality in patients referred to coronary angiography
Harald Sourij et al.
ATHEROSCLEROSIS (2011)
Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder
M. Elizabeth Sublette et al.
BRAIN BEHAVIOR AND IMMUNITY (2011)
Elevated Plasma Ceramides in Depression
Patricia Gracia-Garcia et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2011)
The new '5-HT' hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression
M. Maes et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2011)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Rapid Resolution of Suicidal Ideation After a Single Infusion of an N-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
Nancy DiazGranados et al.
JOURNAL OF CLINICAL PSYCHIATRY (2010)
Metabolomic Differences in Heart Failure Patients With and Without Major Depression
David C. Steffens et al.
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY (2010)
On the Biological Importance of the 3-hydroxyanthranilic Acid: Anthranilic Acid Ratio
L. Gail Darlington et al.
INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH (2010)
Nitric Oxide Synthase Inhibitors as Antidepressants
Gregers Wegener et al.
PHARMACEUTICALS (2010)
Metabolomics-based methods for early disease diagnostics
G. A. Nagana Gowda et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2008)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients
Wendy Chrapko et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice
MH Trivedi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2006)
High activity of acid sphingomyelinase in major depression
J Kornhuber et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Decreased platelet nitric oxide synthase activity and plasma nitric oxide metabolites in major depressive disorder
WE Chrapko et al.
BIOLOGICAL PSYCHIATRY (2004)
Derivation of a definition of remission on the Montgomery-Asberg depression rating scale corresponding to the definition of remission on the Hamilton rating scale for depression
M Zimmerman et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2004)
The epidemiology of major depressive disorder - Results from the National Comorbidity Survey Replication (NCS-R).
RC Kessler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Paroxetine-induced increase in metabolic end products of nitric oxide (vol 23, pg 408, 2003)
N Lara et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2003)
Glutamate receptor ligands:: Synthesis, stereochemistry, and enantiopharmacology of methylated 2-aminoadipic acid analogs
M Guldbrandt et al.
CHIRALITY (2002)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
分享论文
